When myelofibrosis occurs, some people may not have any symptoms, while others have severe symptoms that require immediate treatment. This article will explain the symptoms of myelofibrosis ...

"So built into every myelofibrosis or MPN patient visit ... Other clues that the disease is progressing include patient symptoms, including B symptoms -- drenching night sweats, fatigue that ...

The significant symptom burden of myelofibrosis requires treatment to control symptoms, but the Janus kinase (JAK) inhibitors being used today can cause significant side effects that are hard to ...

Myelofibrosis is a rare cancer that affects your bone marrow, the spongy tissue inside some of your bones. In a healthy person, stem cells in the bone marrow make the red blood cells, white blood ...

Panelists discuss how myelofibrosis progresses from its molecular and genetic origins through various clinical manifestations ...

Around 100,000 Australians live with a rare form of blood cancer, and a new treatment approved by the medicines watchdog is ...

Around 100,000 Australians live with myelofibrosis, which is a rare form of blood cancer. But an Australian-developed drug - ...

Current therapies for myelofibrosis, like Novartis/Incyte's JAK1/2 inhibitor Jakafi (ruxolitinib), can help relieve symptoms of myelofibrosis and improve long-term survival, but can exacerbate ...

The health technology assessment (HTA) agency has recommended Inrebic (fedratinib) for treating disease-related splenomegaly (enlarged spleen) or other symptoms in myelofibrosis in patients ...